CLINICAL-TRIALS OF WR-2721 PRIOR TO ALKYLATING AGENT CHEMOTHERAPY AND RADIOTHERAPY

被引：63
作者：
GLOVER, D
FOX, KR
WEILER, C
KLIGERMAN, MM
TURRISI, A
GLICK, JH
机构：
[1] UNIV PENN,DEPT RADIAT THERAPY,PHILADELPHIA,PA 19104
[2] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104
来源：
PHARMACOLOGY & THERAPEUTICS | 1988年 / 39卷 / 1-3期
关键词：
D O I：
10.1016/0163-7258(88)90032-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3 / 7
页数：5
相关论文
共 28 条
[21]  
WASSERMAN TH, 1981, CANCER CLIN TRIALS, V4, P3
[22]  
WEISMAN RA, 1985, ABSTR AM AC OT HEAD
[23]   EFFICACY TESTING OF WR-2721 IN GREAT-BRITAIN OR EVERYTHING IS BLACK AND WHITE AT THE GRAY LAB [J].
YUHAS, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (04) :595-598
[24]  
YUHAS JM, 1969, J NATL CANCER I, V42, P331
[25]  
YUHAS JM, 1980, CANCER TREAT REP, V64, P57
[26]  
YUHAS JM, 1980, CANCER RES, V40, P1519
[27]   CIRCUMVENTION OF THE TUMOR MEMBRANE BARRIER TO WR-2721 ABSORPTION BY REDUCTION OF DRUG HYDROPHILICITY [J].
YUHAS, JM ;
DAVIS, ME ;
GLOVER, D ;
BROWN, DQ ;
RITTER, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4) :519-522
[28]  
Yuhas JMS, 1980, RAD SENSITIZERS, P303
123